www.fdanews.com/articles/74206-transgene-raises-euro-34-9-million
TRANSGENE RAISES EURO 34.9 MILLION
July 12, 2005
Transgene has announced the results of its capital increase in the form of an offering of shares with warrants (actions a bon de souscription d'actions or ABSA). The company raised a total of euro 34.9 million corresponding to the subscription of 4,657,500 ABSA at euro 7.50. The capital increase being oversubscribed 2.2 times, the 15% extension clause was put into effect. The ABSA were placed mainly in France, Benelux, the UK, Switzerland and Germany.
Yahoo News (http://biz.yahoo.com/prnews/050711/nym010.html?.v=12)